Local reactions following C.B.P.P. vaccination in Zambia.
D000617:Aminoglycosides / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000009:adverse effects*; D002417:Cattle; D002418:Cattle Diseases / Q000209:etiology / Q000517:prevention & control*; D004487:Edema / Q000209:etiology / Q000662:veterinary; D007249:Inflammation; D007279:Injections, Subcutaneous; D007511:Ischemia; D007783:Lactones / Q000627:therapeutic use; D009174:Mycoplasma / Q000276:immunology*; D009175:Mycoplasma Infections / Q000662:veterinary*; D010502:Perineum; D011002:Pleuropneumonia, Contagious / Q000517:prevention & control / Q000662:veterinary*; D013623:Tail / Q000098:blood supply; D014611:Vaccination / Q000662:veterinary*; D015024:Zambia
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D001428:Bacterial Vaccines; D007783:Lactones